Welcome to Oncologica
Oncologica® is a leading precision cancer and COVID genetic testing services laboratory and contract research organisation based in the prestigious Chesterford Research Park, Cambridge, UK.
We have performed more than 5 million analyses in the last year.
COVID Testing and Genomic Sequencing
Easy, fast Lateral Flow Device (LFD) Antigen and PCR self-test kits for certified Covid test results.
Ideal for UK outbound Fit-to-Fly and Non-Travel uses such as workplace or event testing.
The PCR home to lab service or Lateral Flow Test with photo upload both provide verified certificates by our medical team and are ideal for workplace or event testing.
Non-Travel Lateral Flow Test
Our Non-Travel Lateral Flow test can be used for workplace testing or entertainment/hospitality locations that require proof of negative test for entry.
Non-Travel PCR Test
Our Non-Travel PCR test can be used for workplace testing or entertainment/hospitality locations that require confirmation of a positive Lateral Flow.
Non-Travel Lateral Flow 5 Test Kit Packs
£2.80 per kit
Our 5 test kits Lateral Flow pack is ideal for home family or events testing. Non-Travel tests only.
Non-Travel Lateral Flow 10 Test Kit Packs
£2.00 per kit
Our 10 test kits Lateral Flow pack is ideal for home family or events testing. Non-Travel tests only.
Non-Travel Lateral Flow 20 Test Kit Packs
£1.30 per kit
Our 20 test kits Lateral Flow pack is ideal for work, events or business bulk purchasing. Non-Travel tests only.
Non-Travel Lateral Flow 100 Test Kit Packs
£1.00 per kit
Our 100 test kits Lateral Flow pack is ideal for work, events or business bulk purchasing. Non-Travel tests only.
Non-Travel Lateral Flow 240 Test Kit Packs
92p per kit
Our 240 test kits Lateral Flow pack is ideal for work, events or business bulk purchasing. Non-Travel tests only.
Oncologica’s linking of cancer mutations to targeted therapies enables patient tumours to be matched to the most appropriate therapy.
Chemotherapy or radiation therapy targets both healthy and cancerous cells, whereas therapies based on genomic molecular profiling can specifically target the patients tumour.
The New Prostatefocus Genetic Screening Test Identifies Men at Increased Risk of Developing Prostate Cancer
Our new Prostatefocus cancer genetic screening test identifies men at increased risk of developing prostate cancer. Prostate cancer is the most common cancer in men with 50,000 people in the UK diagnosed with the disease each year. 1 in 8 men in the UK will develop...
Our new Allergyfocus test helps sufferers discover what common global allergens their bodies react to. Across the world allergies are on the rise. It is estimated that 20% of children and 30% of adults develop allergies in their lifetime. People can be allergic to...
Oncologica new research on detection of brain cancer biomarkers by genomic sequencing to improve survival rates
Glioblastoma, the most aggressive form of brain cancer is commonly treated with surgery, radiation, and chemotherapy. However, a newly published study from the research team at Oncologica the world-leading genetic cancer testing laboratory based in Cambridge UK,...
Our dedicated customer support team are ready to help you. Submit requests anytime via our Contact Us form - top right of screen, chat with the team via the tab bottom right or phone us on +44 (0) 1223 785327 9am - 5pm BST Mon - Fri.
Find what you need: